Literature DB >> 16646156

Neuronal dysfunction in Down syndrome: contribution of neuronal models in cell culture.

Katherine Saud1, Christian Arriagada, Ana María Cárdenas, Takeshi Shimahara, David D Allen, Raúl Caviedes, Pablo Caviedes.   

Abstract

Down syndrome (DS) in humans, or trisomy of autosome 21, represents the hyperdiploidy that most frequently survives gestation, reaching an incidence of 1 in 700 live births. The condition is associated with multisystemic anomalies, including those affecting the central nervous system (CNS), determining a characteristic mental retardation. At a neuronal level, our group and others have shown that the condition determines marked alterations of action potential and ionic current kinetics, which may underlie abnormal processing of information by the CNS. Since the use of human tissue presents both practical and ethical problems, animal models of the human condition have been sought. Murine trisomy 16 (Ts16) is a model of the human condition, due to the great homology between human autosome 21 and murine 16. Both conditions share the same alterations of electrical membrane properties. However, the murine Ts16 condition is unviable (animals die in utero), thus limiting the quantity of tissue procurable. To overcome this obstacle, we have established immortal cell lines from normal and Ts16 mice with a method developed by our group that allows the stable in vitro immortalization of mammalian tissue, yielding cell lines which retain the characteristics of the originating cells. Cell lines derived from cerebral cortex, hippocampus, spinal cord and dorsal root ganglion of Ts16 animals show alterations of intracellular Ca2+ signals in response to several neurotransmitters (glutamate, acetylcholine, and GABA). Gene overdose most likely underlies these alterations in cell function, and the identification of the relative contribution of DS associated genes on such specific neuronal dysfunction should be investigated. This could enlighten our understanding on the contribution of these genes in DS, and identify new therapeutic targets.

Entities:  

Mesh:

Year:  2006        PMID: 16646156     DOI: 10.1016/j.jphysparis.2005.12.013

Source DB:  PubMed          Journal:  J Physiol Paris        ISSN: 0928-4257


  12 in total

1.  The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.

Authors:  Ahmad Salehi; J Wesson Ashford; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 2.  Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR).

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2018-09-14       Impact factor: 1.827

3.  Altered voltage dependent calcium currents in a neuronal cell line derived from the cerebral cortex of a trisomy 16 fetal mouse, an animal model of Down syndrome.

Authors:  Mario A Acuña; Ramón Pérez-Nuñez; Jorge Noriega; Ana María Cárdenas; Juan Bacigalupo; Ricardo Delgado; Christian Arriagada; Juan Segura-Aguilar; Raúl Caviedes; Pablo Caviedes
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

4.  Knockdown of Myo-Inositol Transporter SMIT1 Normalizes Cholinergic and Glutamatergic Function in an Immortalized Cell Line Established from the Cerebral Cortex of a Trisomy 16 Fetal Mouse, an Animal Model of Human Trisomy 21 (Down Syndrome).

Authors:  Ana María Cárdenas; Paola Fernández-Olivares; Ignacio Díaz-Franulic; Arlek M González-Jamett; Takeshi Shimahara; Juan Segura-Aguilar; Raúl Caviedes; Pablo Caviedes
Journal:  Neurotox Res       Date:  2017-07-10       Impact factor: 3.911

5.  Effects of a Tripeptide on Mitogen-Activated Protein Kinase and Glycogen Synthase Kinase Activation in a Cell Line Derived from the Foetal Hippocampus of a Trisomy 16 Mouse: an Animal Model of Down Syndrome.

Authors:  Tushar Arora; Pablo Caviedes; Shiv Kumar Sharma
Journal:  Neurotox Res       Date:  2019-12-04       Impact factor: 3.911

6.  Overexpressed Down Syndrome Cell Adhesion Molecule (DSCAM) Deregulates P21-Activated Kinase (PAK) Activity in an In Vitro Neuronal Model of Down Syndrome: Consequences on Cell Process Formation and Extension.

Authors:  Ramón Pérez-Núñez; Natalia Barraza; Arlek Gonzalez-Jamett; Ana Maria Cárdenas; Jean-Vianney Barnier; Pablo Caviedes
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

7.  [Urological manifestations of Down syndrome: significance and long-term complications -- our own patient cohort with an overview].

Authors:  A K Ebert; S Brookman-Amissah; W H Rösch
Journal:  Urologe A       Date:  2008-03       Impact factor: 0.639

8.  Restrained Phosphatidylcholine Synthesis in a Cellular Model of Down's Syndrome is Associated with the Overexpression of Dyrk1A.

Authors:  Maruan Hijazi; José M Medina; Ana Velasco
Journal:  Mol Neurobiol       Date:  2016-01-23       Impact factor: 5.590

Review 9.  Down syndrome and the enteric nervous system.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2008-07-17       Impact factor: 1.827

10.  Developmental and maintenance defects in Rett syndrome neurons identified by a new mouse staging system in vitro.

Authors:  Gabriele Baj; Angela Patrizio; Alberto Montalbano; Marina Sciancalepore; Enrico Tongiorgi
Journal:  Front Cell Neurosci       Date:  2014-02-05       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.